Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers

J Clin Pharmacol. 2001 Jun;41(6):655-61. doi: 10.1177/00912700122010546.

Abstract

The single-dose pharmacokinetics of two gastric-retentive, extended-release tablet formulations of metformin hydrochloride in fed, healthy volunteers were compared with those of the currently marketed immediate-release metformin hydrochloride product. The plasma concentration-time profiles demonstrated extended-release characteristics from the gastric-retentive tablets. The mean bioavailability from each gastric-retentive tablet was approximately 115%, relative to the immediate-release (IR) product. Cmax values were lower and tmax values were greater for the gastric-retentive tablets compared with the IR product. In contrast to conventional extended-release metformin tablets reported in the literature, these gastric-retentive tablets showed extended-release plasma concentration profiles of metformin hydrochloride and increased bioavailability compared with the immediate-release tablet.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biological Availability
  • Chemistry, Pharmaceutical
  • Cross-Over Studies
  • Dosage Forms
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / pharmacokinetics
  • Metformin / administration & dosage
  • Metformin / adverse effects
  • Metformin / pharmacokinetics*

Substances

  • Dosage Forms
  • Hypoglycemic Agents
  • Metformin